Literature DB >> 5687589

The analgesic action of morphine-n-oxide.

M R Fennessy.   

Abstract

1. The analgesic activity of morphine-N-oxide in mice and rats has been investigated and compared with that of morphine.2. Both morphine and morphine-N-oxide were more active when given subcutaneously than when given intraperitoneally.3. Given subcutaneously, morphine was 11-22 times more potent than morphine-N-oxide and when given intraperitoneally it was 39-89 times more potent. The potencies depended on the test situation and the species of animal used.4. In animals pretreated with amiphenazole or tacrine, the analgesic activities of morphine and morphine-N-oxide were increased. The potencies of these analgesic drugs given intraperitoneally were increased to a greater extent than were the potencies obtained by subcutaneous administration.5. A possible explanation for the increase in analgesic potency of morphine-N-oxide produced by pretreatment with amiphenazole or tacrine may be that morphine-N-oxide is rapidly inactivated in the liver and this inactivation is impaired by amiphenazole and tacrine.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5687589      PMCID: PMC1703337          DOI: 10.1111/j.1476-5381.1968.tb07055.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  AMIPHENAZOLE IN THE TREATMENT OF MORPHINE AND OPIUM ADDICTION.

Authors:  D W BRUCE
Journal:  Lancet       Date:  1964-05-09       Impact factor: 79.321

2.  The biological disposition of morphine and its surrogates. I.

Authors:  E L WAY; T K ADLER
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

3.  The preparation of tritium nuclear-labeled morphine and evidence for its in vivo biotransformation to normorphine in the rat.

Authors:  A L MISRA; S J MULE; L A WOODS
Journal:  J Pharmacol Exp Ther       Date:  1961-06       Impact factor: 4.030

4.  The treatment of severe pain.

Authors:  F H SHAW
Journal:  Br J Clin Pract       Date:  1960-01

5.  Further experience with amiphenazole and morphine in intractable pain.

Authors:  J MCKEOGH; F H SHAW
Journal:  Br Med J       Date:  1956-01-21

6.  Analgesics and their antagonists: some steric and chemical considerations. III. The influence of the basic group on the biological response.

Authors:  A H BECKETT; A F CASY; N J HARPER
Journal:  J Pharm Pharmacol       Date:  1956-11       Impact factor: 3.765

7.  The enzymatic N-demethylation of narcotic drugs.

Authors:  J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1956-07       Impact factor: 4.030

8.  Effect of hepatectomy upon the analgetic action of 1 methadone.

Authors:  D D BONNYCASTLE; C W DELIA
Journal:  Proc Soc Exp Biol Med       Date:  1950-07

9.  Treatment of Intractable Pain with Morphine and Tetrahydroaminacrine.

Authors:  V Stone; W Moon; F H Shaw
Journal:  Br Med J       Date:  1961-02-18

10.  Distribution and excretion of radioactivity after administration of morphine-N-methyl C14 to rats.

Authors:  C H MARCH; H W ELLIOTT
Journal:  Proc Soc Exp Biol Med       Date:  1954-07
View more
  4 in total

1.  Protocols for the social transfer of pain and analgesia in mice.

Authors:  Benjamin Rein; Erin Jones; Sabrena Tuy; Cali Boustani; Julia A Johnson; Robert C Malenka; Monique L Smith
Journal:  STAR Protoc       Date:  2022-10-11

2.  Comparison of effect of morphine-like analgesics on transmurally stimulated guinea-pig ileum.

Authors:  M R Fennessy; R L Heimans; M J Rand
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

3.  Isolation, characterisation and synthesis of a new quinidine metabolite.

Authors:  T W Guentert; J J Daly; S Riegelman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Jan-Mar       Impact factor: 2.441

4.  Computational Study of Selected Amine and Lactam N-Oxides Including Comparisons of N-O Bond Dissociation Enthalpies with Those of Pyridine N-Oxides.

Authors:  Arthur Greenberg; Alexa R Green; Joel F Liebman
Journal:  Molecules       Date:  2020-08-14       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.